BTN3A1 and prostate neoplasm: In our analysis of the SU2C/PCF Dream Team dataset, we found BTN3A1 and BTN2A1 transcripts to be expressed in bone metastatic tumors at similar levels to prostate tumors and soft tissue metastases to the liver and lymph nodes (Fig. 1C).